KPMG's latest report on China's life science sector notes that the country is set to become a crucial player in the life science and healthcare industry. Within a decade it is expected to become a global leader in drug discovery and innovation.
This report makes a compelling read for any organisation that is either planning or implementing a cloud strategy, and provides some practical and actionable advice for enterprises and their executives.
This First Impressions contains a detailed analysis of the consolidation exception for investment funds, presenting the key facts and impacts along with KPMG’s insight.
Related links
RSS feeds
Subscribe to receive email alerts or e-Newsletters from KPMG China when new updates are available.
IFRS for Investment Funds -Our series of IFRS for Investment Funds publications addresses practical application issues that investment funds may encounter when applying IFRS.
International Financial Reporting Standards - Recently published International Financial Reporting Standards publications.